Virginia Retirement Systems’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.54M | Buy |
48,736
+19,000
| +64% | +$599K | 0.01% | 461 |
|
2025
Q1 | $974K | Buy |
+29,736
| New | +$974K | 0.01% | 563 |
|
2023
Q3 | $562K | Buy |
20,400
+2,000
| +11% | +$55.1K | 0.01% | 661 |
|
2023
Q2 | $553K | Buy |
+18,400
| New | +$553K | 0.01% | 700 |
|
2022
Q1 | – | Sell |
-12,600
| Closed | -$367 | – | 1212 |
|
2021
Q4 | $367 | Sell |
12,600
-10,700
| -46% | -$312 | ﹤0.01% | 937 |
|
2021
Q3 | $621K | Sell |
23,300
-5,500
| -19% | -$147K | 0.01% | 755 |
|
2021
Q2 | $887K | Sell |
28,800
-2,300
| -7% | -$70.8K | 0.01% | 688 |
|
2021
Q1 | $814K | Sell |
31,100
-4,200
| -12% | -$110K | 0.01% | 725 |
|
2020
Q4 | $888K | Sell |
35,300
-4,000
| -10% | -$101K | 0.01% | 643 |
|
2020
Q3 | $819K | Sell |
39,300
-1,300
| -3% | -$27.1K | 0.01% | 598 |
|
2020
Q2 | $964K | Sell |
40,600
-3,900
| -9% | -$92.6K | 0.01% | 572 |
|
2020
Q1 | $801K | Hold |
44,500
| – | – | 0.01% | 629 |
|
2019
Q4 | $1.06M | Buy |
44,500
+100
| +0.2% | +$2.37K | 0.01% | 669 |
|
2019
Q3 | $1.22M | Buy |
44,400
+18,700
| +73% | +$514K | 0.01% | 605 |
|
2019
Q2 | $850K | Sell |
25,700
-8,400
| -25% | -$278K | 0.01% | 725 |
|
2019
Q1 | $1.2M | Buy |
34,100
+1,600
| +5% | +$56.1K | 0.01% | 607 |
|
2018
Q4 | $1.08M | Buy |
32,500
+16,000
| +97% | +$532K | 0.01% | 593 |
|
2018
Q3 | $831K | Sell |
16,500
-6,300
| -28% | -$317K | 0.01% | 767 |
|
2018
Q2 | $1.37M | Sell |
22,800
-6,900
| -23% | -$413K | 0.02% | 577 |
|
2018
Q1 | $1.36M | Sell |
29,700
-17,000
| -36% | -$778K | 0.02% | 557 |
|
2017
Q4 | $1.86M | Sell |
46,700
-5,300
| -10% | -$211K | 0.02% | 493 |
|
2017
Q3 | $2.08M | Sell |
52,000
-16,200
| -24% | -$648K | 0.03% | 489 |
|
2017
Q2 | $2.94M | Sell |
68,200
-3,600
| -5% | -$155K | 0.04% | 378 |
|
2017
Q1 | $2.25M | Buy |
71,800
+10,500
| +17% | +$329K | 0.03% | 445 |
|
2016
Q4 | $1.55M | Buy |
61,300
+4,300
| +8% | +$109K | 0.02% | 471 |
|
2016
Q3 | $1.41M | Buy |
57,000
+45,500
| +396% | +$1.13M | 0.02% | 474 |
|
2016
Q2 | $234K | Buy |
+11,500
| New | +$234K | ﹤0.01% | 875 |
|